# A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment

> **NCT01319279** · PHASE1 · COMPLETED · sponsor: **Cephalon** · enrollment: 16 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Hydrocodone bitartrate extended-release tablet

## Key facts

- **NCT ID:** NCT01319279
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319279, "A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT01319279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*